In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Therapeutic Discovery Corp.

Division of Johnson & Johnson

Latest From Therapeutic Discovery Corp.

Industry Outlook 1999/ Pharmaceuticals

Although times are heady for the pharmaceutical industry, Morgan Stanley Dean Witter analyst Paul Brooke doesn't think the boom will continue. Industry growth will be stymied by genericization and the introduction of fewer big new products. At the same time, the industry faces restraints on its pricing flexibility, one of the keys to its recent success.
BioPharmaceutical Strategy
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Johnson & Johnson
  • Senior Management
  • Gary L Neil, PhD, Pres. & CEO
    David Hoffmann, VP, Fin.
    Suzanne Martin, VP, R&D Admin.
  • Contact Info
  • Therapeutic Discovery Corp.
    Phone: (415) 496-8200
    1454 Page Mill Rd., Ste. 220
    P.O. Box 10051 Palo Alto, CA 94303-0806